Category: Monthly Scientific Update
![](https://cholangiocarcinoma.org/wp-content/uploads/2024/04/Reham-Abdel-Wahab-200x300.jpg)
Monthly Scientific Update – April 2022 (the impact of Capecitabine (Xeloda) as adjuvant therapy for surgically resected biliary tract cancers)
Recently, a group of medical oncologists assessed the long-term outcome of a randomized phase III BILCAP trial to evaluate the impact…
![](https://cholangiocarcinoma.org/wp-content/uploads/2024/04/Carl-Scheitrum.png)
Monthly Scientific Update – March 2022
Carl Scheitrum spent more than 1,000 volunteer hours in 2021 updating the International Cholangiocarcinoma Patient Registry. Carl's information technology experience…